RecruitingNot ApplicableNCT06765291

Behavioral Intervention for Youth to Promote Vaping Cessation


Sponsor

Massachusetts General Hospital

Enrollment

400 participants

Start Date

Jun 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will test the hypothesis that the QuitVaping (QV) intervention and additional texting support will improve nicotine abstinence rates in adolescents as compared to Enhanced Usual Care (EUC: education about nicotine, vaping and addiction, advice to quit vaping, referral to TIQ texting support). Approximately 400 adolescents will be randomly assigned to one of two arms (1) QuitVaping intervention plus texting support to quit vaping and (2) EUC only.


Eligibility

Min Age: 14 YearsMax Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called QuitVaping and a behavioral approach called This is Quitting (TIQ) for people with nicotine dependence, vaping, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 19 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQuitVaping

QuitVaping is a manualized intervention based on the American Lung Association smoking cessation program modified with adolescent appropriate content and language for vaping cessation from the vaping section of teen.smokefree.gov and the Truth Initiative. These behavioral support sessions will be delivered weekly during the 12-week treatment phase via videoconference or in- person.

BEHAVIORALThis is Quitting (TIQ)

A free, publicly available text message vaping cessation program from Truth Initiative, designed specifically to help adolescents who vape nicotine quit. Participants who set a quit date receive messages for a week preceding it and 30 days afterward that include encouragement and support, skill- and self-efficacy building exercises, coping strategies, and information about the risks of vaping, benefits of quitting and cutting down to quit.


Locations(1)

Massachusetts General Hospital, Center for Addiction Medicine, 101 Merrimac Street, Suite 320, Boston, MA 02114

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06765291


Related Trials